Trials / Active Not Recruiting
Active Not RecruitingNCT07329998
The Aim of the Study is to Check Whether Follicular Fluid Evaluation Using a Spectrophotometer Can Differentiate High Quality Oocytes From Low Quality Oocytes. Oocyte Quality Will be Defined Using GDF9, BMP15 and Oocyte Morphology.
Oocyte Quality Assessment Using Spectrophotometer
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Hillel Yaffe Medical Center · Other Government
- Sex
- Female
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to check whether follicular fluid evaluation using a spectrophotometer can differentiate high quality oocytes from low quality oocytes. Oocyte quality will be defined using GDF9, BMP15 and oocyte morphology. The correlation between cortisol levels in women and oocyte quality parameters will be estimated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Oocyte quality assessment using spectrophotometer | On the OPU (ovum pick-up) day the following blood biochemical markers will be measured as well- Blood interleukins 1-6, cytokine, hormone profile, lipid profile, cortisol. After collecting the oocytes- the Follicular fluid will be sent for the following tests- 1. mid-infrared spectrometry, 2. P, E2, testosterone, cortisol, cytokines, IL 1-6, lipids, fatty acids. 3. BMP-15, GDF-9 and HSPG2 4. GCMS-Gas Chromatography Mass Spectrophotometer |
Timeline
- Start date
- 2024-09-22
- Primary completion
- 2025-12-16
- Completion
- 2026-11-01
- First posted
- 2026-01-09
- Last updated
- 2026-01-09
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT07329998. Inclusion in this directory is not an endorsement.